SUBSCRIBE
SUBSCRIBE

Phase I

Drug Development
Why Drugmakers Do Interim Clinical Trials
September 26, 2017
 · 
1 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
3 Biotechs With Make-or-Break Trial Results, FDA Meetings Coming Soon
September 22, 2017
 · 
3 min read
Drug Development
Down But Not Out: Juno Preps For Second Round Of CAR-T Cancer War
September 18, 2017
 · 
1 min read
Roche Slammed With Partial Holds for Two Combo Cancer Trials
Drug Development
Roche Slammed With Partial Holds for Two Combo Cancer Trials
September 18, 2017
 · 
3 min read
Secretive Moderna Shakes Up R&D Model, Shows Off Early-Stage Trial Data
Drug Development
Secretive Moderna Shakes Up R&D Model, Shows Off Early-Stage Trial Data
September 14, 2017
 · 
4 min read
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
Drug Development
FDA Calls Regeneron, Sanofi Carcinoma Drug a Breakthrough
September 8, 2017
 · 
2 min read
Celgene Cuddles Up With Another Cambridge Biotech, This Time to Tackle Autoimmune Diseases
Drug Development
FDA Orders 6 Partial or Full Clinical Holds on Celgene’s Blood Cancer Studies
September 7, 2017
 · 
2 min read
Bristol-Myers Squibb's Stock Topples as Kidney Cancer Drug Flunks Phase III Study
Drug Development
FDA Slaps Partial Hold on 3 of Bristol-Myers Squibb’s Opdivo-Based Combo Trials
September 7, 2017
 · 
3 min read
Drug Development
Thiel-Backed Biotech Rational Vaccines Will Follow FDA Guidelines After Offshore Trial Controversy
September 5, 2017
 · 
1 min read
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
Drug Development
Patient Dies in Cellectis’ Groundbreaking CAR-T Trial, Forcing a Halt to Trials
September 5, 2017
 · 
2 min read
Load More
PRESS RELEASES
Drug Development
Zealand Pharma Presents Results from Phase 1 Clinical Trial of Amylin Analog ZP8396 at ADA Scientific Sessions
June 24, 2023
 · 
6 min read
Drug Development
Sun Pharma Presents Data from First-in-Human Phase 1 Studies of GL0034 at the American Diabetes Association 83rd Scientific Sessions
June 24, 2023
 · 
6 min read
Drug Development
Vertex Presents Positive VX-880 Results From Ongoing Phase 1/2 Study in Type 1 Diabetes at the American Diabetes Association 83rd Scientific Sessions
June 23, 2023
 · 
9 min read
Drug Development
Novel Stem Cell-Derived Islet Cell Therapy Continues to Show Promise for Achieving Insulin Independence for Individuals with Type 1 Diabetes
June 23, 2023
 · 
6 min read
Drug Development
ASLAN Pharmaceuticals Announces Publication in Clinical Immunology Highlighting Eblasakimab’s Unique Mechanism of Action in the Treatment of Atopic Dermatitis
June 23, 2023
 · 
5 min read
Drug Development
Sernova to Present Updated Interim Phase 1/2 Clinical Data on Cell Pouch System™ During Oral Presentation at American Diabetes Association 83rd Scientific Sessions
June 22, 2023
 · 
5 min read
Drug Development
Aptorum Group Updates on a Phase 1b/2a Clinical Trial for Repurposed Small Molecule Drug SACT-1 for Neuroblastoma
June 22, 2023
 · 
4 min read
Drug Development
Palleon Pharmaceuticals Announces First Patient Dosed with E-602 in Combination with Cemiplimab in GLIMMER-01 Phase 1/2 Clinical Trial
June 22, 2023
 · 
2 min read
Drug Development
Vaxxinity Announces UB-312 Successfully Met Primary Objectives of Phase 1 Clinical Trial in Parkinson’s Disease
June 22, 2023
 · 
9 min read
Drug Development
Jasper Therapeutics Announces First Patient Dosed in a Phase 1 Trial of Briquilimab in Lower-Risk Myelodysplastic Syndrome
June 22, 2023
 · 
7 min read
Drug Development
Invivyd Announces Positive Initial Data from Ongoing Phase 1 Clinical Trial of VYD222, a Monoclonal Antibody Candidate in Development for the Prevention of Symptomatic COVID-19 in Immunocompromised People
June 22, 2023
 · 
11 min read
Drug Development
IDEAYA Announces First Reported Case of Uveal Melanoma Patient Spared Enucleation in Phase 1 Neoadjuvant IST with Darovasertib Monotherapy
June 22, 2023
 · 
5 min read
Drug Development
Vistagen Announces Results of Successful U.S. Phase 1 Study of Itruvone (PH10), Enabling U.S. Phase 2B Development for Treatment of Major Depressive Disorder
June 21, 2023
 · 
9 min read
Drug Development
Rani Therapeutics’ Presentation On Oral Delivery of PTH for Osteoporosis Named Presidential Poster Competition Winner at ENDO 2023 Annual Conference
June 21, 2023
 · 
4 min read
Drug Development
uniQure Announces Update on U.S. Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
June 21, 2023
 · 
13 min read
Drug Development
Avacta Announces Successful Completion of Fifth Dose Escalation in AVA6000 Phase 1 Clinical Study
June 21, 2023
 · 
3 min read
Drug Development
BioInvent Reports Strong Interim Safety Data and Early Signs of Efficacy in Phase 1/2a Trial with anti-TNFR2 Antibody BI-1808 in Advanced Malignancies
June 21, 2023
 · 
3 min read
Drug Development
Accutar Biotechnology Announces First Patient Dosed with AC0676 in Phase 1 Study in Patients with Relapsed/Refractory B-cell Malignancies
June 20, 2023
 · 
2 min read
Drug Development
Longbio Pharma Presented Positive Topline Phase 1 Results for LP-003 at ERS2023
June 20, 2023
 · 
3 min read
Drug Development
Sonnet BioTherapeutics Announces Regulatory Approval for Initiation of a Clinical Trial of SON-1010 Combined with Atezolizumab
June 20, 2023
 · 
6 min read
Load More